Gainers
- Missfresh Limited (NASDAQ:MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
- GreenLight Biosciences Holdings (NASDAQ:GRNA) shares rose 100.6% to $6.54 in pre-market trading after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
- Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 74.1% to $0.18 in pre-market trading after dipping around 34% on Wednesday.
- Exicure, Inc. (NASDAQ:XCUR) shares rose 73.4% to $3.45 in pre-market trading after climbing around 27% on Wednesday.
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) shares rose 73% to $0.1955 in pre-market trading after gaining around 9% on Wednesday.
- Greenpro Capital Corp. (NASDAQ:GRNQ) rose 38.8% to $2.43 in pre-market trading after climbing around 14% on Tuesday after climbing 28% on Wednesday.
- Yellow Corporation (NASDAQ:YELL) rose 32.9% to $6.26 in pre-market trading after the company swung to a profit for the second quarter.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) shares rose 31.4% to $0.23 in pre-market trading.
- Embark Technology, Inc. (NASDAQ:EMBK) rose 28.7% to $0.6641 in pre-market trading.
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares rose 24.2% to $5.49 in pre-market trading after gaining over 12% on Wednesday.
- Legacy Housing Corporation (NASDAQ:LEGH) rose 24.1% to $16.76 in pre-market trading. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported.
- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) rose 22.8% to $1.08 in pre-market trading. Syros receives positive opinion on orphan drug designation from the European Medicines Agency for Tamibarotene for the treatment of MDS.
- Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
- RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 16.2% to $1.13 in pre-market trading after gaining more than 6% on Wednesday.
- Kaixin Auto Holdings (NASDAQ:KXIN) rose 15.8% to $1.39 in pre-market trading after the company announced $700 million intended investments at conversion price of $2 and above for pending acquisition of a new energy vehicle manufacturer.
- Exela Technologies, Inc. (NASDAQ:XELA) rose 15.7% to $1.69 in pre-market trading after the company announced an update on its capital deployment strategy. Exela Technologies says the company has purchased $70 million of face value 2026 Senior Secured Notes at a discount with funds raised from equity. This will be the first contribution to the company's STS ("Serve the Shareholders") initiative.
- Crawford & Company (NYSE: CRD-B) shares rose 15.4% to $8.02 in pre-market trading.
- Digital Brands Group, Inc. (NASDAQ:DBGI) rose 14.5% to $0.1374 in pre-market trading. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance.
- Avalon Holdings Corporation (NYSE:AWX) rose 13.2% to $3.78 in pre-market trading after surging 29% on Wednesday.
- MercadoLibre, Inc. (NASDAQ:MELI) rose 12.5% to $1,002.66 in pre-market trading following better-than-expected quarterly results.
- Benitec Biopharma Inc. (NASDAQ:BNTC) rose 12.5% to $0.89 in pre-market trading.
- Synthetic Biologics, Inc. (NYSE:SYN) rose 12.2% to $1.66 in pre-market trading. Synthetic Biologics recently announced a $3 million private placement of convertible preferred stock.
- Playtika Holding Corp. (NASDAQ:PLTK) rose 11.7% to $14.56 in pre-market trading.
- CASI Pharmaceuticals, Inc. (NASDAQ:CASI) rose 10.7% to $2.67 in pre-market trading.
- Sunrun Inc. (NASDAQ:RUN) rose 9% to $33.52 in pre-market trading after the company reported better-than-expected financial results.
- Albemarle Corporation (NYSE:ALB) rose 5.7% to $253.17 in pre-market trading after the company posted upbeat Q2 earnings and raised FY22 forecast.
- Novo Nordisk A/S (NYSE:NVO) rose 4.7% to $104.63 in pre-market trading. Novo Nordisk reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis).
- Crocs, Inc. (NASDAQ:CROX) rose 4.3% to $80.70 in pre-market trading.
